Nomura Holdings’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25,706
Closed -$558K 2067
2025
Q4
$558K Buy
+25,706
New +$507K ﹤0.01% 1500
2025
Q1
Sell
-56,989
Closed -$674K 2294
2024
Q4
$674K Buy
+56,989
New +$674K ﹤0.01% 1668
2024
Q3
Sell
-19,046
Closed -$217K 1935
2024
Q2
$201K Buy
+19,046
New +$209K ﹤0.01% 1612

Other funds holding ROIV

Nomura Holdings's ROIV Position: Q1 2026 in Review

Nomura Holdings sold out of Roivant Sciences (ROIV) in Q1 2026, closing a stake of 25,706 shares — an estimated $558K sold.

Nomura Holdings first reported a position in ROIV in Q2 2024 and held it in 3 quarters. The position peaked at $674K in Q4 2024. 442 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Nomura Holdings reported no remaining Roivant Sciences position as of Q1 2026 after selling out during the quarter.
  • Nomura Holdings sold 25,706 Roivant Sciences shares in Q1 2026, an estimated $558K.
  • Nomura Holdings first reported a position in Roivant Sciences in Q2 2024 and held it in 3 quarters.
  • Nomura Holdings's Roivant Sciences position peaked at $674K in Q4 2024.
  • 442 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.